The Treatment Situation of Chinese County Population With Breast Cancer
NCT05544123 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2500
Last updated 2023-01-04
Summary
The study is a multi-center, non-interventional, prospective observational study which enrols 2500 breast cancer patients from China county area. The purpose of this study is to be aware of the real-world data of the current breast cancer diagnosis and treatment model in the county. It aims to understand the gap between the county and the SOC in the diagnosis and treatment.
Conditions
- Breast Cancer
- Breast Carcinoma
- Breast Tumor
Interventions
- OTHER
-
pathological stage
breast cancer molecular subtyping and pathological TNM stage
Sponsors & Collaborators
- collaborator INDUSTRY
-
The First Affiliated Hospital of Xinxiang Medical College
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-29
- Primary Completion
- 2023-08-31
- Completion
- 2024-09-30
Countries
- China
Study Locations
More Related Trials
-
Miti-gene Recurrence Score in HR+/HER2- Chinese Breast Cancer Patients
NCT07052734 ·Status: COMPLETED
-
Prognostic Value of Biomarkers in HR + / HER2 - Advanced Breast Cancer
NCT04683770 ·Status: UNKNOWN
-
A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast
NCT03047889 ·Status: UNKNOWN
-
Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy
NCT01198301 ·Status: COMPLETED
-
Characteristics and Treatment Trends of Young Breast Cancer in China
NCT05068115 ·Status: UNKNOWN
-
Familial Breast Cancer in China
NCT06833216 ·Status: NOT_YET_RECRUITING
-
Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients
NCT05326295 ·Status: RECRUITING
-
Treatment Intermittent Periods Based on ctDNA-MRD(Circulating Tumor DNA-minimal Residual Disease) Status in Advanced HER2-Positive Breast Cancer
NCT07132502 ·Status: NOT_YET_RECRUITING
-
Research on the Potential Mechanisms Underlying the Efficacy Differences in Specific Neoadjuvant Treatment Regimens for Different Subtypes of Breast Cancer
NCT07012720 ·Status: RECRUITING ·Phase: NA
-
Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer
NCT04065321 ·Status: RECRUITING
-
Breast Tissue Study of Breast Diseases Among Women in Hong Kong
NCT01885039 ·Status: COMPLETED
-
Clinical Study on Triple Negative Breast Cancer With Chinese Medicine
NCT03332368 ·Status: UNKNOWN
-
A Study of Patients With HER2-Positive Metastatic Breast Cancer
NCT00105456 ·Status: COMPLETED
-
Evaluation of Prognostic Monitoring for Breast Cancer Patients With Recurrence and Metastasis After Surgery
NCT04145973 ·Status: UNKNOWN
-
Ethnic Predisposition, Risk Factors & Breast Cancer Presentation.
NCT05458570 ·Status: COMPLETED
-
Observational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast Cancer
NCT06918262 ·Status: RECRUITING
-
99mTc-MIRC213 SPECT/CT for the Detection of HER2-positive Breast Cancer
NCT05622240 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study
NCT05463276 ·Status: COMPLETED
-
Regional Radiotherapy Omission in Low-Risk Node Positive Breast Cancer
NCT07179744 ·Status: RECRUITING
-
99mTc Labelled Affibody SPECT/CT Imaging for Breast Cancer HER2 Characterization
NCT03546478 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer
NCT06718010 ·Status: RECRUITING
-
99mTc-3PRGD2 SPECT/CT in Breast Cancer Patients
NCT02742168 ·Status: COMPLETED ·Phase: NA
-
Studying Blood Samples in Women With Breast Cancer or a History of Breast Cancer
NCT00898703 ·Status: COMPLETED
-
Tumor Immune Mechanism of Axillary Lymph Node Metastasis in Early Luminal Type A Breast Cancer
NCT04322331 ·Status: UNKNOWN
-
99mTc-ABH2 SPECT/CT in Breast Cancer
NCT06194565 ·Status: RECRUITING ·Phase: NA